Trade
Trading Type
Spot
Trade crypto freely
Alpha
Points
Get promising tokens in streamlined on-chain trading
Pre-Market
Trade new tokens before they are officially listed
Margin
Magnify your profit with leverage
Convert & Block Trading
0 Fees
Trade any size with no fees and no slippage
Leveraged Tokens
Get exposure to leveraged positions simply
Futures
Futures
Hundreds of contracts settled in USDT or BTC
Options
HOT
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Participate in events to win generous rewards
Demo Trading
Use virtual funds to experience risk-free trading
Earn
Launch
Investment
Simple Earn
VIP
Earn interests with idle tokens
Auto-Invest
Auto-invest on a regular basis
Dual Investment
Buy low and sell high to take profits from price fluctuations
Quant Fund
VIP
Top asset management team helps you profit without hassle
Crypto Loan
0 Fees
Pledge one crypto to borrow another
Lending Center
One-Stop Lending Hub
VIP Wealth Hub
New
Customized wealth management empowers your assets growth
Private Wealth Management
Customized asset management to grow your digital assets
Staking
Stake cryptos to earn in PoS products
BTC Staking
HOT
Stake BTC and earn 10% APR
GUSD Minting
New
Use USDT/USDC to mint GUSD for treasury-level yields
Soft Staking
Earn rewards with flexible staking
More
- Trending TopicsView More
115.6K Popularity
26.7K Popularity
15.7K Popularity
171.2K Popularity
2.3K Popularity
- Pin
Silo Pharma, a publicly traded company in the US stock market, announced its first purchase of RSC Token.
On October 6, according to official news, Silo Pharma, Inc. (NASDAQ: SILO), a diversified biopharmaceutical and crypto asset management company, announced today its first acquisition of ResearchCoin (RSC) as an important measure to expand its digital asset management strategy, aiming to gain long-term value from emerging multi-chain opportunities. RSC is the native token of ResearchHub, a decentralized research collaboration platform co-founded by CEX CEO Brian Armstrong in 2019. Silo Pharma CEO Eric Weissblum stated: "By laying out RSC, we are participating in the increasingly robust Decentralization Science (DeSci) movement while also diversifying assets and potential appreciation for our shareholders. Our investment in ResearchCoin highlights our focus on the modernization of research collaboration and our support for blockchain-driven innovation as a pillar of biomedical discovery."